MindBio Therapeutics Corp.

C$0.09As of Sun 8 Nov 2026, 12:00 UTC
CSE:MBIOHealthcare
Country Canada
PE (Fwd) •••
TSR 3Y CAGR (81.51%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.75)
PE TTM —
TSR TTM (95.50%)
Mkt cap C$0.655M
ROIC (1843.29%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.111
23.02%
37.70%
Hold 0|1|1|3|0
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
23.07%
19.74%
23.36%
38.16%
Revenue$M
0.066
0.065
0.068
0.067
0.35%
0.24%
2.47%
3.72%
Peers (US$0.464M)
Cap (US$)
PE
0.310M
1.003x
0.453M
—
Capital
TTM
5Y
10Y
Leveragex
3.070
0.441
0.410
EBIT/Intx
16.45
0.304
0.219
Own earn%
(69.82)
139.17
146.06
Sh yield%
21.32
28.04
28.30
Owners
Insiders/Inst%
2.34
29.16
Short interest%
1.57
SBC / revenue%
3.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
2–7
$1 testx
—
Incr. ROIC%
9